U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels

U.S. FDA Approves Second Bayer Oral Contraceptive That Also Raises Folate Levels
Bayer HealthCare Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved a new oral contraceptive (OC), SAFYRAL™ (drospirenone 3 mg/ ethinyl estradiol 30 mcg/ levomefolate calcium 451 mcg tablets and levomefolate calcium 451 mcg tablets).
Read more on PharmaceuticalOnline


Related Articles
All people in this planet earth have experienced headache of any kind. Actually,

symptoms of a migraine